Article: SALICK HEALTH CARE NAMES DR. ROBERT PETER GALE CORPORATE DIRECTOR OF BONE MARROW AND STEM CELL TRANSPLANTATION PROGRAMS

Appointment of Internationally Acclaimed Physician/Scientist Underscores

 
Company's Leadership in Quality, Cost-Effective Cancer Treatment 
LOS ANGELES, July 27 /PRNewswire/ -- Salick Health Care Inc. (NASDAQ: SHCI) today named Robert Peter Gale, M.D., Ph.D., as its corporate director of Bone Marrow and Stem Cell Transplantation Programs.  Gale assumes the newly created position Sept. 1.  He will expand the company's existing services in these areas while developing national programs for Salick Health Care in the area of new and emerging cancer therapies. 
Gale is an international expert in leukemia and cancer treatment and bone marrow transplantation.  He is ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!